Hussein A Tawbi (Hussein Tawbi, H Tawbi)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 56

Top Topics

Clinical Practice

Brain Metastases

Top Venues

Journal for immunotherapy of cancer

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer 5 (4) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 15 (1) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery (2024)
Chantal Saberian, Denái R Milton, Julie Simon, Rodabe N Amaria, Adi Diab, Jennifer McQuade, Sapna P Patel, Hussein A Tawbi, Cassian Yee, Michael K Wong, Ian E McCutcheon, Michael A Davies, Sherise D Ferguson, Isabella C Glitza Oliva
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neuro-oncology practice 11 (4) (2024)
Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein A Tawbi, Jeffrey Weber, Keith Flaherty, Grant A McArthur, Paolo A Ascierto, Yanina Pfluger, Karl Lewis, Katy K Tsai, Omid Hamid, Hans Prenen, Luis Fein, Erjian Wang, Carolin Guenzel, Fan Zhang, Joseph F Kleha, Alessandra di Pietro, Michael A Davies
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis. Neuro-oncology advances 6 (1) (2024)
Georgina V Long, Evan J Lipson, F Stephen Hodi, Paolo Antonio Ascierto, James M G Larkin, Christopher Lao, Jean-Jacques Grob, Flavia Ejzykowicz, Andriy Moshyk, Viviana Garcia-Horton, Zheng-Yi Zhou, Yiqiao Xin, Jennell Palaia, Laura McDonald, Sarah Keidel, Anthony Salvatore, Divya Patel, Leon A Sakkal, Hussein A Tawbi, Dirk Schadendorf
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Chantal Saberian, Denái R Milton, Julie Simon, Rodabe N Amaria, Adi Diab, Jennifer McQuade, Sapna P Patel, Hussein A Tawbi, Cassian Yee, Michael K Wong, Ian E McCutcheon, Michael A Davies, Sherise D Ferguson, Isabella C Glitza Oliva
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neuro-oncology practice 11 (4) (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer 5 (4) (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein A Tawbi, Jeffrey Weber, Keith Flaherty, Grant A McArthur, Paolo A Ascierto, Yanina Pfluger, Karl Lewis, Katy K Tsai, Omid Hamid, Hans Prenen, Luis Fein, Erjian Wang, Carolin Guenzel, Fan Zhang, Joseph F Kleha, Alessandra di Pietro, Michael A Davies
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis. Neuro-oncology advances 6 (1) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Christina Lynn Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J F Lazar, Heather Lin, Manoj Chelvanambi, Edwin Roger Parra Cuentes, Khalida Wani, B Ashleigh Guadagnolo, Andrew J Bishop, Elizabeth M Burton, Kelly K Hunt, Keila E Torres, Barry W Feig, Christopher P Scally, Valerae O Lewis, Justin E Bird, Ravin Ratan, Dejka Araujo, M Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P Conley, Jonathan A Livingston, Vinod Ravi, Hussein A Tawbi, Patrick P Lin, Bryan S Moon, Robert L Satcher, Bilal Mujtaba, Russell G Witt, Raymond S Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M Mohammad, Randy A Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F Lima, Jean Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, P Andrew Futreal, Nadim Ajami, Jennifer A Wargo, Neeta Somaiah
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature cancer 5 (4) (2024)
Isabella C Glitza Oliva, Sherise D Ferguson, Roland L Bassett, Alexandra P Foster, Ida John, Tarin D Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Dett, Carol Lacey, Natalie Jackson, Theresa Rodgers, Suzanne Phillips, Sheila Duncan, Lauren Haydu, Ruitao Lin, Rodabe N Amaria, Michael K Wong, Adi Diab, Cassian Yee, Sapna Pradyuman Patel, Jennifer Leigh McQuade, Grant M Fischer, Ian E McCutcheon, Barbara J O'Brien, Sudhakar Tummala, Matthew Debnam, Nandita Guha-Thakurta, Jennifer A Wargo, Fernando C L Carapeto, Courtney W Hudgens, Jason T Huse, Michael T Tetzlaff, Elizabeth M Burton, Hussein A Tawbi, Michael A Davies
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nature medicine (2024)
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, Helen X Chen, Robert L Ferris, Sarah B Goldberg, Matthew D Hellmann, Ranee Mehra, Ina Rhee, Jong Chul Park, Harriet M Kluger, Hussein A Tawbi, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos A Torres-Cabala, Isabella C Glitza Oliva, Fei Duan, Denái R Milton, Klaus J Busam, Lauren Simpson, Jennifer Leigh McQuade, Michael K Wong, Jeffrey E Gershenwald, Jeffrey E Lee, Ryan P Goepfert, Emily Z Keung, Sarah B Fisher, Allison Betof Warner, Alexander N Shoushtari, Margaret K Callahan, Daniel Coit, Edmund K Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna Pradyuman Patel, Adi Diab, Anthony Lucci, Victor G Prieto, Michael A Davies, James P Allison, Padmanee Sharma, Jennifer A Wargo, Charlotte Ariyan, Hussein A Tawbi
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature (2023)
Kari B Wisinski, Yael Flamand, Melissa A Wilson, Jason John Luke, Hussein A Tawbi, Fangxin Hong, Edith P Mitchell, James A Zwiebel, Helen Chen, Robert C Gray, Shuli Li, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Robert J Behrens, Kathryn P Pennington, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Trametinib in Patients With NF1- , GNAQ- , or GNA11 -Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 7 (2023)
Christopher P Vellano, Michael G White, Miles C Andrews, Manoj Chelvanambi, Russell G Witt, Joseph R Daniele, Mark Titus, Jennifer Leigh McQuade, Fabio Conforti, Elizabeth M Burton, Matthew J Lastrapes, Gabriel Ologun, Alexandria P Cogdill, Golnaz Morad, Peter Prieto, Alexander J F Lazar, Yanshuo Chu, Guangchun Han, Md Abdul Wadud Khan, Beth Helmink, Michael A Davies, Rodabe N Amaria, Jeffrey J Kovacs, Scott E Woodman, Sapna Pradyuman Patel, Patrick Hwu, Michael Peoples, Jeffrey E Lee, Zachary A Cooper, Haifeng Zhu, Guang Gao, Hiya Banerjee, Mike Lau, Jeffrey E Gershenwald, Anthony Lucci, Emily Z Keung, Merrick I Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla Borthwick Bowen, Eric Lau, Melinda S Yates, Shannon Neville Westin, Khalida Wani, Michael T Tetzlaff, Lauren E Haydu, Mikhila Mahendra, XiaoYan Ma, Christopher L Logothetis, Zachary Kulstad, Sarah B Johnson, Courtney W Hudgens, Ningping Feng, Lorenzo Federico, Georgina V Long, P Andrew Futreal, Swathi Arur, Hussein A Tawbi, Amy E Moran, Linghua Wang, Timothy P Heffernan, Joseph R Marszalek, Jennifer A Wargo
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature (2023)
Michael B Atkins, Paolo Antonio Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet M Kluger, Ryan J Sullivan, Hussein A Tawbi
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Journal for immunotherapy of cancer 11 (3) (2023)
Paolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, James M G Larkin, Georgina V Long, Rachel E Sanborn, Vanna Chiarion Sileni, Brigitte Dreno, Stéphane Dalle, Dirk Schadendorf, Margaret K Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez Roca, Naoya Yamazaki, Hussein A Tawbi, Naomey Sarkis, Deepti M Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, Jean-Jacques Grob
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Harriet M Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein A Tawbi, Elad Sharon
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (3) (2023)
Harriet M Kluger, Hussein A Tawbi, David Feltquate, Theresa LaVallee, Naiyer A Rizvi, Elad Sharon, Jeffrey Sosman, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development. Journal for immunotherapy of cancer 11 (7) (2023)
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, Helen X Chen, Robert L Ferris, Sarah B Goldberg, Matthew D Hellmann, Ranee Mehra, Ina Rhee, Jong Chul Park, Harriet M Kluger, Hussein A Tawbi, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Michael B Atkins, Paolo Antonio Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet M Kluger, Ryan J Sullivan, Hussein A Tawbi
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Journal for immunotherapy of cancer 11 (3) (2023)
Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo Antonio Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph Hoeller, Roland Kaufmann, Celeste Lebbè, Mario Mandala, Alexander M Menzies, David Moreno, Olivier Michielin, Paul Nathan, Sapna Pradyuman Patel, Caroline Robert, Dirk Schadendorf, Paul C Lorigan, Richard A Scolyer, Hussein A Tawbi, Bart A van de Wiel, Christian U Blank, Georgina V Long
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nature medicine (2023)
Joanne M Jeter, Lisa A Kottschade, Robert R McWilliams, Nikhil I Khushalani, Sekwon Jang, Sigrun Hallmeyer, David H McDermott, Hussein A Tawbi, Min Che, Cho-Han Lee, Corey Ritchings, Trong Kim Le, Boas Park, Scott D Ramsey
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study. Immunotherapy (2023)
Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, Diwakar Davar, Geoffrey Thomas Gibney, Omid Hamid, Tina J Hieken, Benjamin Izar, Douglas B Johnson, Rajan P Kulkarni, Jason John Luke, Tara C Mitchell, Meghan J Mooradian, Krista M Rubin, April Ks Salama, Keisuke Shirai, Janis M Taube, Hussein A Tawbi, J Keith Tolley, Caressa Valdueza, Sarah A Weiss, Michael K Wong, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. Journal for immunotherapy of cancer 11 (10) (2023)
Harriet M Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein A Tawbi, Elad Sharon
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (3) (2023)
Isabella C Glitza Oliva, Sherise D Ferguson, Roland L Bassett, Alexandra P Foster, Ida John, Tarin D Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Dett, Carol Lacey, Natalie Jackson, Theresa Rodgers, Suzanne Phillips, Sheila Duncan, Lauren Haydu, Ruitao Lin, Rodabe N Amaria, Michael K Wong, Adi Diab, Cassian Yee, Sapna Pradyuman Patel, Jennifer Leigh McQuade, Grant M Fischer, Ian E McCutcheon, Barbara J O'Brien, Sudhakar Tummala, Matthew Debnam, Nandita Guha-Thakurta, Jennifer A Wargo, Elizabeth M Burton, Hussein A Tawbi, Michael A Davies
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nature medicine (2023)
Hussein A Tawbi, Caroline Robert, Jan C Brase, Daniel Gusenleitner, Eduard Gasal, James Garrett, Alexander Savchenko, Güllü Görgün, Keith T Flaherty, Antoni Ribas, Reinhard Dummer, Dirk Schadendorf, Georgina V Long, Paul D Nathan, Paolo Antonio Ascierto
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i). Journal for immunotherapy of cancer 10 (6) (2022)
Alexander M Menzies, Ines Pires da Silva, Claudia Trojaniello, Elisabeth Vieu, Rodabe N Amaria, Lisa Zimmer, Serigne N Lo, Elizabeth M Burton, Hussein A Tawbi, Dirk Schadendorf, Jean J Grob, Paolo Antonio Ascierto, Georgina V Long
CTLA-4 Blockade Resistance after Relatlimab and Nivolumab. The New England journal of medicine 386 (17) (2022)
Christopher P Vellano, Michael G White, Miles C Andrews, Manoj Chelvanambi, Russell G Witt, Joseph R Daniele, Mark Titus, Jennifer Leigh McQuade, Fabio Conforti, Elizabeth M Burton, Matthew J Lastrapes, Gabriel Ologun, Alexandria P Cogdill, Golnaz Morad, Peter Prieto, Alexander J F Lazar, Yanshuo Chu, Guangchun Han, Md Abdul Wadud Khan, Beth Helmink, Michael A Davies, Rodabe N Amaria, Jeffrey J Kovacs, Scott E Woodman, Sapna Pradyuman Patel, Patrick Hwu, Michael Peoples, Jeffrey E Lee, Zachary A Cooper, Haifeng Zhu, Guang Gao, Hiya Banerjee, Mike Lau, Jeffrey E Gershenwald, Anthony Lucci, Emily Z Keung, Merrick I Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla Borthwick Bowen, Eric Lau, Melinda S Yates, Shannon Neville Westin, Khalida Wani, Michael T Tetzlaff, Lauren E Haydu, Mikhila Mahendra, XiaoYan Ma, Christopher L Logothetis, Zachary Kulstad, Sarah B Johnson, Courtney W Hudgens, Ningping Feng, Lorenzo Federico, Georgina V Long, P Andrew Futreal, Swathi Arur, Hussein A Tawbi, Amy E Moran, Linghua Wang, Timothy P Heffernan, Joseph R Marszalek, Jennifer A Wargo
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 606 (7915) (2022)
Claire F Friedman, Christine Spencer, Christopher R Cabanski, Katherine S Panageas, Daniel K Wells, Antoni Ribas, Hussein A Tawbi, Katy Tsai, Michael A Postow, Alexander N Shoushtari, Paul B Chapman, Joyson Karakunnel, Samantha Bucktrout, Pier Gherardini, Travis J Hollmann, Richard O Chen, Margaret Callahan, Theresa LaVallee, Ramy Ibrahim, Jedd Wolchok
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses. Journal for immunotherapy of cancer 10 (1) (2022)
Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, Paolo Antonio Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen J Gogas, Christopher D Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Arance, Jean-Jacques Grob, Shivani Srivastava, Mena Abaskharoun, Melissa Hamilton, Sarah Keidel, Katy L Simonsen, Anne Marie Sobiesk, Bin Li, F Stephen Hodi, Georgina V Long, null null
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. The New England journal of medicine 386 (1) (2022)
Ayal A Aizer, Nayan Lamba, Manmeet S Ahluwalia, Kenneth Aldape, Adrienne A Boire, Priscilla K Brastianos, Paul D Brown, D Ross Camidge, Veronica L Chiang, Michael A Davies, Leland S Hu, Raymond Y Huang, Timothy Kaufmann, Priya U Kumthekar, Keng Lam, Eudocia Q Lee, Nancy U Lin, Minesh Mehta, Michael W Parsons, David A Reardon, Jason Sheehan, Riccardo Soffietti, Hussein A Tawbi, Michael Weller, Patrick Y Wen
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro-oncology 24 (10) (2022)
Reinhard Dummer, Georgina V Long, Caroline Robert, Hussein A Tawbi, Keith T Flaherty, Paolo Antonio Ascierto, Paul D Nathan, Piotr Lukasz Rutkowski, Oleg Leonov, Caroline Dutriaux, Mario Mandala, Paul C Lorigan, Pier Francesco Ferrucci, Jean-Jacques Grob, Nicolas Meyer, Helen J Gogas, Daniil Stroyakovskiy, Ana M Arance, Jan C Brase, Steven Green, Tomas Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, Jennifer Wang, Amishi Yogesh Shah, Nizar M Tannir, Matthew T Campbell, Don L Gibbons, Cascone Tina, Charles Lu, George R Blumenschein, Mehmet Altan, Bora Lim, Vincente Valero, Monica E Loghin, Janet Tu, Shannon Neville Westin, Aung Naing, Guillermo Garcia Manero, Noha Abdel-Wahab, Hussein A Tawbi, Patrick Hwu, Isabella C Glitza Oliva, Michael A Davies, Sapna Pradyuman Patel, Jun Zou, P Andrew Futreal, Adi Diab, Linghua Wang, Roza Nurieva
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nature communications 13 (1) (2022)
Chantal Saberian, Rodabe N Amaria, Amer M Najjar, Laszlo G Radvanyi, Cara L Haymaker, Marie-Andrée Forget, Roland L Bassett, Silvana C Faria, Isabella C Glitza Oliva, Enrique Alvarez, Sapna Parshottam, Victor Prieto, Gregory Lizée, Michael K Wong, Jennifer L McQuade, Adi Diab, Cassian Yee, Hussein A Tawbi, Sapna Pradyuman Patel, Elizabeth J Shpall, Michael A Davies, Patrick Hwu, Chantale Bernatchez
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. Journal for immunotherapy of cancer 9 (5) (2022)
Walter J Storkus, Deena Maurer, Yan Lin, Fei Ding, Anamika Bose, Devin Lowe, Amy Rose, Melissa DeMark, Lilit Karapetyan, Jennifer L Taylor, Manoj Chelvanambi, Ronald J Fecek, Jessica N Filderman, Timothy J Looney, Lauren Miller, Elizabeth Linch, Geoffrey M Lowman, Pawel Kalinski, Lisa H Butterfield, Ahmad A Tarhini, Hussein A Tawbi, John M Kirkwood
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. Journal for immunotherapy of cancer 9 (11) (2022)
James S Wilmott, Hussein A Tawbi, Johnathan A Engh, Nduka M Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A Vergara, Hansol Lee, Peter A Johansson, Peter M Ferguson, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Lisa H Butterfield, Richard A Scolyer, Joanne M Jeter, Georgina V Long, Michael A Davies
Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib treatment in patients with BRAF-mutant melanoma brain metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tezlaff, Merrick I Ross, Carlos A Torres-Cabala, Isabella C Glitza Oliva, Fei Duan, Denái R Milton, Klaus J Busam, Lauren Simpson, Jennifer Leigh McQuade, Michael K Wong, Jeffrey E Gershenwald, Jeffrey E Lee, Ryan P Goepfert, Emily Z Keung, Sarah B Fisher, Allison Betof Warner, Alexander N Shoushtari, Margaret K Callahan, Daniel Coit, Edmund K Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna Pradyuman Patel, Adi Diab, Anthony Lucci, Victor G Prieto, Michael A Davies, James P Allison, Padmanee Sharma, Jennifer A Wargo, Charlotte Ariyan, Hussein A Tawbi
Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611 (7934) (2022)
Alexander M Menzies, Rodabe N Amaria, Elisa A Rozeman, Alexander C Huang, Michael T Tetzlaff, Bart A van de Wiel, Serigne N Lô, Ahmad A Tarhini, Elizabeth M Burton, Thomas E Pennington, Robyn P M Saw, Xiaowei Xu, Giorgos C Karakousis, Paolo Antonio Ascierto, Andrew J Spillane, Alexander C J van Akkooi, Michael A Davies, Tara C Mitchell, Hussein A Tawbi, Richard A Scolyer, Jennifer A Wargo, Christian U Blank, Georgina V Long
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). Nature medicine 27 (2) (2021)
Hussein A Tawbi, Tu My To, Karen Bartley, Natalia Sadetsky, Elizabeth Burton, Lauren E Haydu, Edward McKenna
Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study. Cancer medicine (2021)
Paolo Antonio Ascierto, Carlo Bifulco, Jerome Galon, Claus Garbe, Samir N Khleif, Jennifer McQuade, Kunle Odunsi, Hideho Okada, Chrystal M Paulos, Sergio A Quezada, Hussein A Tawbi, John Timmerman, Giorgio Trinchieri, Lisa H Butterfield, Igor Puzanov
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019. Journal for immunotherapy of cancer 8 (2) (2021)
Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, Christopher D Lao, Stergios J Moschos, Omid Hamid, Michael B Atkins, Karl Lewis, Reena P Thomas, John A Glaspy, Sekwon Jang, Alain P Algazi, Nikhil I Khushalani, Michael A Postow, Anna C Pavlick, Marc S Ernstoff, David A Reardon, Igor Puzanov, Ragini R Kudchadkar, Ahmad A Tarhini, Anne Sumbul, Jasmine I Rizzo, Kim A Margolin
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204). Neuro-oncology 23 (11) (2021)
Anisha B Patel, Sahira Farooq, Macartney Welborn, Rodabe N Amaria, Susan Y Chon, Adi Diab, Isabella C Glitza Oliva, Auris O Huen, Shirley Q Li, Kelly C Nelson, Omar Pacha, Sapna Pradyuman Patel, Ronald P Rapini, Hussein A Tawbi, Michael K Wong, Jennifer McQuade, Michael A Davies, Lauren E Haydu
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit. Cancer (2021)
Miles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, Wei-Shen Chen, Lisa Derosa, Md Abdul Wadud Khan, Alexandria P Cogdill, Michael G White, Matthew C Wong, Gladys Ferrere, Aurélie Fluckiger, Maria Paula Roberti, Paule Opolon, Maryam Tidjani Alou, Satoru Yonekura, Whijae Roh, Christine N Spencer, Irina Fernandez Curbelo, Luis Vence, Alexandre Reuben, Sarah Johnson, Reetakshi Arora, Golnaz Morad, Matthew Lastrapes, Erez N Baruch, Latasha Little, Curtis Gumbs, Zachary A Cooper, Peter A Prieto, Khalida Wani, Alexander J F Lazar, Michael T Tetzlaff, Courtney W Hudgens, Margaret K Callahan, Matthew J Adamow, Michael A Postow, Charlotte E Ariyan, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Catalin Mihalcioiu, Arielle Elkrief, Rossanna C Pezo, Lauren E Haydu, Julie M Simon, Hussein A Tawbi, Jennifer Leigh McQuade, Patrick Hwu, Wen-Jen Hwu, Rodabe N Amaria, Elizabeth M Burton, Scott E Woodman, Stephanie S Watowich, Adi Diab, Sapna P Patel, Isabella C Glitza, Michael K Wong, Li Zhao, Jianhua Zhang, Nadim J Ajami, Joseph Petrosino, Robert R Jenq, Michael A Davies, Jeffrey E Gershenwald, P Andrew Futreal, Padmanee Sharma, James P Allison, Bertrand Routy, Laurence Zitvogel, Jennifer A Wargo
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nature medicine 27 (8) (2021)
Jianbo Wang, Hussein A Tawbi
Emergent immunotherapy approaches for brain metastases. Neuro-oncology advances 3 (Suppl 5) (2021)
Joseph D Butner, Zhihui Wang, Dalia Elganainy, Karine A Al Feghali, Marija Plodinec, George A Calin, Prashant Dogra, Sara Nizzero, Javier Ruiz-Ramírez, Geoffrey V Martin, Hussein A Tawbi, Caroline Chung, Eugene Jon Koay, James W Welsh, David S Hong, Vittorio Cristini
A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nature biomedical engineering 5 (4) (2021)
Christine N Spencer, Jennifer Leigh McQuade, Vancheswaran Gopalakrishnan, John A McCulloch, Marie Vetizou, Alexandria P Cogdill, Md Abdul Wadud Khan, Xiaotao Zhang, Michael G White, Christine B Peterson, Matthew C Wong, Golnaz Morad, Theresa Rodgers, Jonathan H Badger, Beth A Helmink, Miles C Andrews, Richard Rosario Rodrigues, Andrey Morgun, Young S Kim, Jason Roszik, Kristi L Hoffman, Jiali Zheng, Yifan Zhou, Yusra B Medik, Laura M Kahn, Sarah B Johnson, Courtney W Hudgens, Khalida Wani, Pierre-Olivier Gaudreau, Angela L Harris, Mohamed A Jamal, Erez Nissim Baruch, Eva Perez-Guijarro, Chi-Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S Lochmann, Robert A Szczepaniak-Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M Simon, Lauren E Haydu, Elizabeth M Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah M Schneider, Thomas Chapman, Nana-Ama A S Anang, Sheila Duncan, Joseph Toker, Jared C Malke, Isabella C Glitza Oliva, Rodabe N Amaria, Hussein A Tawbi, Adi Diab, Michael K Wong, Sapna Pradyuman Patel, Scott E Woodman, Michael A Davies, Merrick I Ross, Jeffrey E Gershenwald, Jeffrey E Lee, Patrick Hwu, Vanessa B Jensen, Yardena Samuels, Ravid Straussman, Nadim J Ajami, Kelly C Nelson, Luigi Nezi, Joseph F Petrosino, P Andrew Futreal, Alexander J F Lazar, Jianhua Hu, Robert R Jenq, Michael T Tetzlaff, Yan Yan, Wendy S Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S Watowich, James P Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R Daniel-MacDougall, Jennifer A Wargo
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science (New York, N.Y.) 374 (6575) (2021)
Reinhard Dummer, Celeste Lebbé, Victoria Atkinson, Mario Mandalà, Paul D Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A Tawbi, Paolo Antonio Ascierto, Antoni Ribas, Keith T Flaherty, Neha Pakhle, Catarina D Campbell, Daniel Gusenleitner, Aisha Masood, Jan C Brase, Eduard Gasal, Georgina V Long
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nature medicine 26 (10) (2020)
Whijae Roh, Pei-Ling Chen, Alexandre Reuben, Christine N Spencer, Peter A Prieto, John P Miller, Vancheswaran Gopalakrishnan, Feng Wang, Zachary A Cooper, Sangeetha M Reddy, Curtis Gumbs, Latasha Little, Qing Chang, Wei-Shen Chen, Khalida Wani, Mariana Petaccia De Macedo, Eveline Chen, Jacob L Austin-Breneman, Hong Jiang, Jason Roszik, Michael T Tetzlaff, Michael A Davies, Jeffrey E Gershenwald, Hussein A Tawbi, Alexander J F Lazar, Patrick Hwu, Wen-Jen Hwu, Adi Diab, Isabella C Glitza Oliva, Sapna P Patel, Scott E Woodman, Rodabe N Amaria, Victor G Prieto, Jianhua Hu, Padmanee Sharma, James P Allison, Lynda Chin, Jianhua Zhang, Jennifer A Wargo, P Andrew Futreal
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Science translational medicine 9 (379) (2017)
Vancheswaran Gopalakrishnan, Christine N Spencer, Luigi Nezi, Alexandre Reuben, Miles C Andrews, T V Karpinets, P A Prieto, Diego A Vicente, Kristi L Hoffman, Spencer C Wei, Alexandria P Cogdill, Li Zhao, Courtney W Hudgens, D S Hutchinson, T Manzo, M Petaccia de Macedo, T Cotechini, Tapsi Kumar, Wei-Shen Chen, S M Reddy, Robert A Szczepaniak Sloane, J Galloway-Pena, H Jiang, P L Chen, E J Shpall, Katayoun Rezvani, A M Alousi, R F Chemaly, Samuel A Shelburne Iii, L M Vence, Pablo C Okhuysen, V B Jensen, A G Swennes, Florencia McAllister, Erick Riquelme, Yu Zhang, Emmanuelle Le Chatelier, L Zitvogel, Nicolas Pons, Jacob L Austin-Breneman, L E Haydu, E M Burton, Julie M Simon, E Sirmans, J Hu, Alexander J F Lazar, Takahiro Tsujikawa, Adi Diab, Hussein A Tawbi, Isabella C Glitza Oliva, Wen-Jen Hwu, Sapna Pradyuman Patel, S E Woodman, R N Amaria, Michael A Davies, Jeffrey E Gershenwald, Patrick Hwu, Jeffrey E Lee, J Zhang, Lisa M Coussens, Zachary A Cooper, P Andrew Futreal, C R Daniel, Nadim J Ajami, Joseph F Petrosino, Michael T Tetzlaff, Padmanee Sharma, James P Allison, Robert R Jenq, Jennifer A Wargo
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (New York, N.Y.) 359 (6371) (2017)